Skip to main content
. 2021 Oct 16;101:108232. doi: 10.1016/j.intimp.2021.108232

Table 1.

Variants of SARS-CoV-2 based on three nomenclature methods, location and date of detection, and the location of mutations in the genome of the virus.

GISAID clades
PANGO lineages Nextstrain clades Notable and elevated risk variants WHO label First detection
Mutations
Location Date
S A.1–A.6 19B “reference sequence” hCoV-19/Wuhan/WIV04/2019 (WIV04) Shenzhen China Jan 2020 C8782T,T28144C includes NS8-L84S
L
B.3-B.7, B.9, B.10, B.13–B.16 19A Wuhan
China
Dec 2019 C241,C3037,A23403,C8782,G11083,G26144,T28144
O France Jan 2020
V B.2 South Korea Feb 2020 G11083T,G26144T NSP6-L37F + NS3-G251V
G






























B.2
B.1.5–B.1.72
20A
20A/S:S477N
(EU2)
Australia, western Europe Jun-Oct 2020
Outbreak
[63], [64], [67]
S:S477N, N:M234I, N:A376T, ORF1b:A176S, ORF1b:V767L, ORF1b:K1141R, ORF1b:E1184D
G/484 K.V3
20A/S.484 K
(B.1.525)
Eta
(VOI)
North America, Europe, Asia, Africa, and Australia late 2020 S:A67V, S:E484K, D614G,S:Q677H, S:F888L, N:A12G
deletion of S: 69, 70, 144
deletion of ORF1a (3675–3677)
20A/S:439 K emerged twice independently in Europe Apr 2020
[63], [65], [76]
S:S439K
ORF1a:I2501T
deletion of S: 69
20A/S:98F Belgium Jul 2020 S:S98F, N:P199L, ORF3a:Q38R, ORF3a:G172R
ORF3a:V202L
A.23.1 Uganda Oct 2020
[77]
S:F157L, S:V367F, S:Q613H, S:P681R

B.1.9, B.1.13, B.1.22, B.1.26, B.1.37
21A/S:154 K B.1.617.1
G/452R.V3
Kappa
(VOI)
India October 2020 S) L452R, E484Q, D614G, P681R, E154K, Q1071H)
21A/S:478 K B.1.617.2
G/452R.V3
Delta
(VOC)
India October 2020 S(L452R, D614G, P681R, T19R, R158G, T478K, D950N),
GH





B.1.3–B.1.66




20C

21F
Derived from 20A,
CAL.20C
20C/S.452R
(B.1.427/B.1.429)
Epsilon
(VOI)
United States [78], Southern California October 2020
[64]
S:S13I, S:W152C, S:L452R, ORF1a:I4205V, ORF1b:D1183Y
20C/S.484 K, (B.1.526) Iota
(VOI)
USA, particularly in New York state
Late 2020 S:L5F, S:T95I, S:D253G, S:E484K, S:A701V, ORF1b:Q1011H, ORF3a:P42L
N:P199L, N:M234I, ORF8:T11I
deletion of ORF1a (3675–3677)
20G
(“20C-US”)
Derived from 20C
S:677H.Robin1
USA
dominant in Wisconsin
Jan '21
[69]
S:Q677H, N:P67S, N:P199L, N:D377Y, ORF1a:T265I, ORF1a:L3352F, ORF1b:N1653D, ORF1b:R2613C
20G/S:677P.Pelican USA. dominant in Louisiana early 2021
[69]
S:Q677P, N:P67S, N:P199L, ORF1a:T265I
ORF1a:L3352F, ORF1b:N1653D
ORF1b:R2613C
21H B.1.621 Mu
(VOI)
Colombia Jan 2021 T95I, Y144S, Y145N, R346K, E484K
N501Y, D614G, P681H, D950N


20H
Derived from 20C
(B.1.351)
20H:501Y.V2
Beta (VOC) South Africa
Dec 2020
[79]
S:N501Y, K417N, E484K, S:L18F and S:D80A
deletion of ORF1a (3675–3677)
deletion at Spike positions 242-245
mutation in Nucleocapsid:N:T205I
GR



B.1.1
20B B.1.1.207 Nigeria Mar 2020 P681H
20B/S:1122L
(B.1.1302)
Sweden, Norway and Denmark Jul 2020 S:V1122L
20B/S:626S
(B1.1.277)
Norway, Denmark, UK Jul 2020 S:A626S
20 J 20 J/S:501Y.V3
(B.1.1.28.1)
(P.1)
Gamma
(VOC)
Brazil, Japan
[72]
January 2021 S:N501Y, S:E484K, S:D614G S:K417T
S: L18F, S: K417N, S: H655Y.
deletion of ORF1a (3675–3677)
N:P80R N:R203K, N:G204R
20D
Derived from 20B
20B/S.484 K
(P.2)
Zeta
(VOI)
Brazil January 2021 S:E484K, N:A119S, N:M234I, ORF1a:L3458V , ORF1a:L3930F
20B/S:265C

P.3

Theta
(VOI)
Philippines
Jan-2021 S (E484K, N501Y, D614G, P681H, E1092K, H1101Y, V1176F)
ORF1ab (L3201P, D3681E, L3930F, P4715L),
ORF8 (K2Q), N (R203K,G204R)
20D GR/452Q.V1
C.37
Lambda
(VOI)
Peru Jun 2021 G75V, T76I, R246N, DEL247/253, L452Q, F490S, D614G, T859N
20F
Derived from 20B
Australia Jun-Oct 2020 outbreak S:S477N
20I
Derived from 20B
GRY
(B.1.1.7)
20I/S:501Y.V1
Alpha
(VOC)
United Kingdom
[80]
18 Dec 2020 S:N501Y, S:A570D
69–70del, P681H (adjacent to the furin cleavage site). deletion of ORF8 (3675–3677) and ORF1a(Nsp6) Q27
GV B.1.177 20E (EU1) Derived from 20A, 20I/501Y.V1 Spain
[81]
early summer of 2020 S:A222V
ORF10:V30L
N:A220V